D-0529-2025 Class III Ongoing
FDA drug recall D-0529-2025 was initiated by AvKARE on Jun 26, 2025 and is designated Class III. Reason for recall: Failed Impurity/Degradation Specifications The recall status is ongoing. Affected quantity: 8,573 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 9, 2025
- Initiation Date
- Jun 26, 2025
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,573 bottles
Product description
Pitavastatin Tablets, 2 mg, 90 Tablets per bottle, Rx Only, Manufactured for: AvKARE, Pulaski, TN 38478. NDC: 42291-906-90
Reason for recall
Failed Impurity/Degradation Specifications
Distribution pattern
Nationwide in the USA
Code information
Lot, expiry: Lot 46211, exp 10/31/2025; Lot 47683, exp 05/31/2026; Lot 46944 , exp 01/31/2026
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0529-2025
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026